We are live on
!
Find out more
AC
Argentiere Capital Portfolio holdings
AUM
$15.4M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
-2.51%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$259M
AUM Growth
+$24.5M
(+10%)
Cap. Flow
+$269M
Cap. Flow
% of AUM
104.04%
Top 10 Holdings %
Top 10 Hldgs %
71.6%
Holding
85
New
30
Increased
14
Reduced
3
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$83.6M |
| 2 |
SHPG
Shire pic
SHPG
|
+$15.3M |
| 3 |
COL
Rockwell Collins
COL
|
+$13.5M |
| 4 |
NXP Semiconductors
NXPI
|
+$9.92M |
| 5 |
JPMorgan Chase
JPM
|
+$9.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$36.9M |
| 2 |
AET
Aetna Inc
AET
|
+$35.2M |
| 3 |
MON
Monsanto Co
MON
|
+$19.8M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$15.2M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$8.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.25% |
| 2 | Healthcare | 12.38% |
| 3 | Energy | 11.99% |
| 4 | Technology | 10.72% |
| 5 | Consumer Discretionary | 3.82% |
Similar funds
TCM
HCA
DPA
MP
MMPI
AF
KAM
BA
Argentiere Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Argentiere Capital held 85 positions worth $259M, up 10% from $234M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Argentiere Capital deployed $269M of net new capital in Q2 2018, opening 30 new positions and adding to 14 existing holdings. Its largest new stake was SPDR Gold Trust: 675,000 shares worth $80.1M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $3.07M trimmed.
- Argentiere Capital's largest Q2 2018 buy was SPDR Gold Trust: 675,000 shares worth $80.1M.
- Argentiere Capital added most to NXP Semiconductors in Q2 2018, an estimated $9.92M increase.
- Argentiere Capital's biggest Q2 2018 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.07M.
- Argentiere Capital fully exited Time Warner Inc in Q2 2018, selling an estimated $36.9M.
- Argentiere Capital's ten largest holdings make up 72% of its $259M portfolio in Q2 2018.
- Argentiere Capital opened 30 new positions and closed 27 in Q2 2018.
- Argentiere Capital's portfolio value rose 10% quarter-over-quarter to $259M.
Based on Argentiere Capital's 13F filing for Q2 2018, filed 14 Aug 2018.